Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Weloxin CL
Weloxin CL (Ampicillin and Cloxacillin Capsules 500 mg) combines two potent antibiotics: Ampicillin and Cloxacillin, to provide a broad-spectrum treatment for various bacterial infections. Ampicillin acts as a broad-spectrum penicillin, effective against both Gram-positive and Gram-negative bacteria, while Cloxacillin is specifically used for infections caused by penicillin-resistant staphylococci. This combination provides enhanced antimicrobial activity, making Weloxin CL highly effective for treating infections in the respiratory, urinary, and skin systems.
Uses of Weloxin CL
Treatment of Respiratory Tract Infections (e.g., pneumonia, bronchitis)
Management of Skin and Soft Tissue Infections (e.g., abscesses, cellulitis)
Treatment of Urinary Tract Infections (UTIs)
Prevention of Post-surgical Infections
Management of Infections Caused by Penicillin-Resistant Staphylococcus
Benefits of Weloxin CL
Broad-Spectrum Antibiotic Action
Effective Against Both Gram-Positive and Gram-Negative Bacteria
Targets Penicillin-Resistant Staphylococcal Infections
Rapid Relief from Bacterial Infection Symptoms
Reduces the Risk of Complications Due to Untreated Infections
Mechanism of Action of Weloxin CL
Ampicillin in Weloxin CL works by binding to bacterial cell wall enzymes, inhibiting cell wall synthesis, and causing bacterial cell death. Cloxacillin effectively targets penicillin-resistant staphylococci by resisting beta-lactamase degradation, which would otherwise inactivate other antibiotics. This combination ensures synergistic activity against a broad range of bacterial pathogens, facilitating faster healing and infection resolution.